This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Chr Hansen-Novozymes reviews likely to focus on dairy enzyme overlaps, vertical integration in distribution

By Flavia Fortes ( August 24, 2023, 22:53 GMT | Comment) -- As regulators across the globe review the Chr Hansen-Novozymes merger, overlaps in the distribution of dairy enzymes, particularly lactase — where the parties said they both operate globally — are likely to be a key focal point. The vertical integration between Novozymes’ production of enzymes and distribution by Chr Hansen is also likely to come under scrutiny from competition regulators, even though the relationship precedes the deal.As regulators across the globe review the Chr Hansen-Novozymes merger, overlaps in distribution of dairy enzymes, particularly lactase — where the parties said they both operate globally — are likely to be a key focal point....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login